文献速递MDS 与骨髓增殖性肿瘤

骨髓增生异常综合征中剪接因子突变的独特与趋同后果

Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes.
PubMed 文献 · Am J Hematol · 2019-11-18

研究对携带剪接因子突变(SF3B1、SRSF2、U2AF1热点突变,SRSF2小缺失,ZRSR2截短突变)且无其他常见共突变的MDS骨髓样本进行RNA测序,揭示各突变组的剪接改变图谱。SRSF2小缺失导致最多剪接改变;不同突变组的错误剪接事件大多不重叠,但包括EZH2在内的部分基因在多组中异常剪接。通路分析显示错误剪接基因富集于RNA剪接与运输及多个信号级联,提示不同剪接体突变下游存在趋同生物学后果。

要点

  • SRSF2小缺失在MDS中导致最高数量的剪接改变。
  • 不同剪接因子突变的错误剪接事件大多不重叠,但EZH2等基因在多组中异常剪接。
  • 错误剪接基因富集于RNA剪接、运输及信号通路,提示趋同生物学后果。

核心结论

  • 不同剪接因子突变导致独特剪接特征,但共享部分错误剪接基因和生物学通路。

研究设计与样本

  • 对携带剪接因子突变且无其他常见共突变的MDS骨髓样本进行RNA测序。

主要发现

  • SRSF2小缺失导致最高数量的剪接改变。
  • 不同剪接因子突变的错误剪接事件大多不重叠。
  • EZH2等多个突变组中异常剪接。
  • 验证了USP9X、USP24、LUC7L2和EED在SRSF2小缺失MDS中的异常剪接。
  • 错误剪接基因富集于RNA剪接、运输及多个信号级联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myelodysplastic syndromes (MDS) are characterized by recurrent somatic alterations often affecting components of RNA splicing machinery. Mutations of splice factors SF3B1, SRSF2, ZRSR2 and U2AF1 occur in >50% of MDS. To assess the impact of spliceosome mutations on splicing and to identify common pathways/genes affected by distinct mutations, we performed RNA-sequencing of MDS bone marrow samples harboring spliceosome mutations (including hotspot alterations of SF3B1, SRSF2 and U2AF1; small deletions of SRSF2 and truncating mutations of ZRSR2), and devoid of other common co-occurring mutations. We uncover the landscape of splicing alterations in each splice factor mutant MDS and demonstrate that small deletions in SRSF2 cause highest number of splicing alterations compared with other spliceosome mutations. Although the mis-spliced events observed in different splice factor mutations were largely non-overlapping, a subset of genes, including EZH2, were aberrantly spliced in multiple mutant groups. We also verified aberrant splicing of key genes USP9X, USP24 (deubiquitinating enzymes), LUC7L2 (splice factor) and EED (PRC2 component) in MDS harboring small deletions of SRSF2. Pathway analysis revealed that mis-spliced genes in different mutant groups were enriched in RNA splicing and transport as well as several signaling cascades, suggesting converging biological consequences downstream of distinct spliceosome mutations. Our study reveals splicing signatures of each splice factor mutation and identifies shared and distinct sets of mis-spliced genes and affected biological processes in different spliceosome mutant MDS.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Madan V, Li J, Zhou S, et al. Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes. Am J Hematol. 2019. PMID: 31680297. doi:10.1002/ajh.25673

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。